PMID: 9430311Jan 16, 1998Paper

Glutamate in neurologic diseases

Journal of Child Neurology
P Bittigau, C Ikonomidou

Abstract

Excitotoxicity has been implicated as a mechanism of neuronal death in acute and chronic neurologic diseases. Cerebral ischemia, head and spinal cord injury, and prolonged seizure activity are associated with excessive release of glutamate into the extracellular space and subsequent neurotoxicity. Accumulating evidence suggests that impairment of intracellular energy metabolism increases neuronal vulnerability to glutamate which, even when present at physiologic concentrations, can damage neurons. This mechanism of slow excitotoxicity may be involved in neuronal death in chronic neurodegenerative diseases such as the mitochondrial encephalomyopathies, Huntington's disease, spinocerebellar degeneration syndromes, and motor neuron diseases. If so, glutamate antagonists in combination with agents that selectively inhibit the multiple steps downstream of the excitotoxic cascade or help improve intracellular energy metabolism may slow the neurodegenerative process and offer a therapeutic approach to treat these disorders.

References

Apr 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P Campochiaro, J T Coyle
Oct 26, 1979·Brain Research·J W OlneyT de Gubareff
Mar 1, 1975·Journal of Neuropathology and Experimental Neurology·J W OlneyT de Gubareff
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T StorckW Stoffel
Jan 1, 1992·Neuron·Y TanabeS Nakanishi
Jan 1, 1992·Trends in Pharmacological Sciences·A I Faden, S Salzman
Apr 22, 1992·European Journal of Pharmacology·Z A Bortolotto, G L Collingridge
Jul 1, 1992·Epilepsy Research·B S Meldrum
Jan 1, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·B Nellgård, T Wieloch
Feb 29, 1992·Lancet·W Pulsinelli
Mar 1, 1992·Epilepsy Research·N A JanjuaO Hatase
Aug 14, 1992·European Journal of Pharmacology·D MartinJ V Nadler
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D K SimonM Constantine-Paton
Sep 1, 1992·Epilepsy Research·D G FujikawaC G Wasterlain
Nov 1, 1992·Archives of Biochemistry and Biophysics·H IschiropoulosJ S Beckman
Nov 1, 1992·Archives of Biochemistry and Biophysics·J S BeckmanM Tsai
Oct 1, 1992·Current Opinion in Neurobiology·M F Beal
Nov 1, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·L VelisekR Schickerova
Jun 1, 1992·Stroke; a Journal of Cerebral Circulation·S E Smith, B S Meldrum
Jun 1, 1992·Stroke; a Journal of Cerebral Circulation·D XueA M Buchan
May 11, 1992·Annals of the New York Academy of Sciences·A C LudolphP S Spencer
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·V L DawsonS H Snyder
Aug 1, 1991·Archives of Biochemistry and Biophysics·R RadiB A Freeman
May 17, 1991·European Journal of Pharmacology·N McGuinnessM Rowan
Dec 3, 1991·European Journal of Pharmacology·S Otani, Y Ben-Ari

❮ Previous
Next ❯

Citations

Sep 24, 1999·Journal of Neuroscience Research·M P Mattson, A J Bruce-Keller
Apr 24, 2007·Neurotoxicity Research·Angela M Kaindl, Chrysanthy Ikonomidou
Jun 1, 2004·Brain Research Bulletin·Gao JingJames Weyhenmeyer
Apr 13, 2000·Brain Research. Brain Research Reviews·A Contestabile
May 30, 2001·Advanced Drug Delivery Reviews·D MorinJ Tillement
Feb 16, 2011·ACS Chemical Neuroscience·Ann M Larsen, Lennart Bunch
Jan 10, 2003·Paediatric Anaesthesia·Hideaki HayashiSulpicio G Soriano
Oct 6, 2010·Antioxidants & Redox Signaling·Chrysanthy Ikonomidou, Angela M Kaindl
Oct 28, 1999·Current Opinion in Ophthalmology·N N OsborneJ P Wood
Jun 10, 2000·Current Opinion in Ophthalmology·R Ritch
Mar 27, 2013·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Keisuke YoshikawaAtsuyoshi Shimada
Jan 18, 2011·The Journal of Sexual Medicine·Michael D StaudtLique M Coolen
Jan 5, 2011·Neuroscience and Biobehavioral Reviews·Diane Dufour-RainfrayChristian R Andres
May 15, 2010·European Journal of Pharmacology·Krzysztof ŁukawskiStanisław J Czuczwar
May 28, 2008·Journal of the Neurological Sciences·Guy HaimanAriel Miller
Jun 15, 2007·Experimental Neurology·M Beth Zimmer, Harry G Goshgarian
Apr 17, 2007·Journal of the Neurological Sciences·Ariel Miller, Hillel Panitch
Jul 9, 2005·Research in Developmental Disabilities·Kristen S L LamL Eugene Arnold

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.